Report overview
Bursitis is a swelling or inflammation of the bursa ? a sac filled with a lubricating fluid and located between the tissues such as bone, skin, tendons and muscles. Lubricating fluid helps in reducing the friction, rubbing and irritation upon movement of a joint. Bursitis affects mainly elbow, hip, shoulder, knee and Achilles tendon. The most common symptoms of bursitis are pain, swelling and stiffness in affected area. Sudden or severe pain may gradually build up, if there is a presence of calcium deposits. Bursitis is commonly caused by the repetitive trauma of injuries on the affected area. Improper posture at home, work and poor stretching before exercise also lead to bursitis. A poorly or an abnormal placed bone or joint can put extra stress on a bursa sac, causing bursitis. Infection from other conditions such as thyroid disorder gout, or unusual medication reactions also increase a person?s risk for bursitis. Sometimes an infection can sometimes lead to inflammation of a bursa. In adults bursitis is very common especially those over 40 years of age. There are number of ways for bursitis treatment like resting the injured area, icing the area, avoiding activities that aggravate the problem, taking over the counter anti-inflammatory medicines and many more. Surgery may be an option when bursitis does not respond to the other treatment options but it is rarely needed.
This report aims to provide a comprehensive presentation of the global market for Bursitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bursitis Treatment. This report contains market size and forecasts of Bursitis Treatment in global, including the following market information:
Global Bursitis Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Bursitis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global bursitis treatment market is driven by the increasing geriatric population highly prone to the bone injury. Another factor which can influence the growth of global bursitis market can be rising number of sports related injuries. Moreover, increasing incidence of elbow joint pain and R&D investment by pharmaceutical companies etc. are the factors which are driving the global bursitis market. However, lack of awareness towards bursitis treatment options, low treatment rate due to absence of signs and symptoms of bursitis are some factors limiting the growth of global bursitis treatment market.
We surveyed the Bursitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bursitis Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Bursitis Treatment Market Segment Percentages, by Type, 2022 (%)
Corticosteroids
Antibiotic
Analgesics
Others
Global Bursitis Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Bursitis Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Global Bursitis Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Bursitis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bursitis Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Bursitis Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical
Crecent Therapeutics
Arinna Lifesciences Private
Sun Pharmaceutical Industries
Bioanalytical Systems
Perrigo Company
Arbor Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bursitis Treatment, market overview.
Chapter 2: Global Bursitis Treatment market size in revenue.
Chapter 3: Detailed analysis of Bursitis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bursitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
